http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105596330-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2015-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105596330-B
titleOfInvention Application and drug of the virtual screening compound in preparing kinase inhibitor
abstract The present invention provides the application and drug of a kind of virtual screening compound in preparing kinase inhibitor, which is with the compound of structure shown in Formulas I, Formula II, formula III or formula IV or its pharmaceutically acceptable salt, ester, solvate.It is verified by vitro kinase activity, above compound has excellent inhibitory activity for VEGFR2, FGFR1, HER2, SRC or Braf kinases.It can be used for the diagnosing and treating of kinase mediated disease.
priorityDate 2015-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013144191-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104725362-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501329
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30705
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395323
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID386966
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25589
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39564
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID461315
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14182
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID839585
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505709
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID796537
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13866
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24337
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44259
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2260
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407170
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID482154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396516
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35968
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2064
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID394418
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16542
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554230
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100856477
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3791

Total number of triples: 53.